The study includes 150 subjects divided into two arms, with one focusing on patients with RHO gene mutations and the other ...

One arm will include participants with the RHO gene mutation, while the other will be gene agnostic, allowing for a more inclusive approach to treatment. This design underlines a shift towards ...